Eli Lilly & Co. (LLY) Tops Q3 EPS by $1.88, Beats on Revenue; Offers FY26 Guidance

October 29, 2026 6:48 AM EDT

Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $7.48, $1.88 better than the analyst estimate of $5.60. Revenue for the quarter came in at $24.4 billion versus the consensus estimate of $22.42 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2026 EPS of $35.00-$36.00, versus the consensus of $34.46. Eli Lilly & Co. sees FY2026 revenue of $91-92 billion, versus the consensus of $88.7 billion.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK